Elizabeth Gibb, MD
Associate Professor
Pediatrics
School of Medicine

Dr. Elizabeth Gibb cares for children with complicated medical conditions and their families, with a commitment to managing their care both over time and during severe episodes.

Show full bio (110 words) Hide full bio

She specializes in treating asthma, bronchopulmonary dysplasia, interstitial lung disease, cystic fibrosis, primary ciliary dyskinesia, sleep apnea and respiratory conditions related to neuromuscular disease, as well as in performing flexible bronchoscopy and pulmonary function tests. Her research focuses on Cystic Fibrosis treatments.

Dr. Gibb earned a master of philosophy degree in biochemistry at the University of Cambridge and her medical degree from Harvard Medical School. She completed a residency in pediatrics and a fellowship in pediatric pulmonary medicine at UCSF. She is a member of the American Academy of Pediatrics. She wrote, produced and directed a UCSF teaching video on pediatric asthma.

Education & Training

Show all (5) Hide

• Pediatric Pulmonary Fellowship University of California, San Francisco 2013
• Pediatric Residency University of California, San Francisco 2010
• MD Harvard 2007
• M. Phil Biochemistry University of Cambridge 2003
• B.S. Molecular, Cellular and Developmental Biology Yale 2002

Interests

Show all (11) Hide

• Health disparities
• BPD
• Pulmonary Function Testing
• Cystic Fibrosis Transmembrane Conductance Regulator
• Cystic Fibrosis
• Interstitial lung disease
• Asthma
• Primary Ciliary Dyskinesia
• Chronic lung disease of prematurity
• Technology dependent children
• Ineffective airway clearance

Websites

Show all (1) Hide

• Dr. Gibb Clinical (ucsfbenioffchildrens.org)

Videos

Show all (3) Hide

• Asthma English (youtube.com)
• Asthma Spanish (youtube.com)
• Sleep Video (youtube.com)

Publications (9)

Top publication keywords:
Drug CombinationsMeconiumTissue Plasminogen ActivatorCystic FibrosisChloride Channel AgonistsHeterozygoteEosinophiliaPulmonary AtelectasisAirway ObstructionCystic Fibrosis Transmembrane Conductance RegulatorAminophenolsShort Bowel SyndromeBenzodioxolesBronchitisInstillation, Drug

• Time to be blunt: Substance use in cystic fibrosis.
  Pediatric pulmonology 2024 Vaziri S, McGarry ME, Huang CY, Cuneo AA, Willen SM, Iwanaga K, Neemuchwala F, Gibb ER, Chan M, Ly NP
• Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report.
  Pediatric pulmonology 2023 Stoffella S, Ly N, McGarry M, Neemuchwala F, Church G, Chan M, Cuneo A, Omori M, Gibb E
• How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
  Pediatric pulmonology 2023 McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT
• Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households.
  Pediatric pulmonology 2022 Lim JT, Ly NP, Willen SM, Iwanaga K, Gibb ER, Chan M, Church GD, Neemuchwala F, McGarry ME
• Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis.
  Paediatric respiratory reviews 2021 McGarry ME, Gibb ER, Oates GR, Schechter MS

Show all (4 more) Hide

• Patient and Provider Experience With Cystic Fibrosis Telemedicine Clinic.
  Frontiers in pediatrics 2021 Hendra K, Neemuchwala F, Chan M, Ly NP, Gibb ER
• Functional Profiling of CFTR-Directed Therapeutics Using Pediatric Patient-Derived Nasal Epithelial Cell Models.
  Frontiers in pediatrics 2020 Park JK, Shrivastava A, Zhang C, Pollok BA, Finkbeiner WE, Gibb ER, Ly NP, Illek B
• Asthma, FEF25-75, and Hospitalizations in Children.
  Pediatric allergy, immunology, and pulmonology 2013 Gibb ER, Thyne SM, Kaplan DN, Ly NP
• Management of plastic bronchitis with topical tissue-type plasminogen activator.
  Pediatrics 2012 Gibb E, Blount R, Lewis N, Nielson D, Church G, Jones K, Ly N